Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 948-134-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
Due to lack of quantitative data,the default ECHA absorption rates of 100% by inhalation and 50% for oral and dermal routes are assumed.This basically indicates that, although the absorption may be lower it is assumed that inhalation results in twice the exposure that occurs with oral or dermal exposure. Very likely this means an overestimation of the inhalation and dermal absorption compared to oral route. Available studies do not indicate a concern for bioaccumulation.
Key value for chemical safety assessment
- Bioaccumulation potential:
- low bioaccumulation potential
- Absorption rate - oral (%):
- 50
- Absorption rate - dermal (%):
- 50
- Absorption rate - inhalation (%):
- 100
Additional information
Physical-chemical properties
The test substance, N-[3-(dimethylamino)propyl] C6-9 alkyl amides has a molecular weight around 200and is aclear amber liquidat 20°C. Its melting point is considered to be< -30°C, the measured boiling point isnot determined as it decomposes at 360°C at 1013 hPa and a vapour pressure of< 0.1 psi (limit of method), < 689Pa. was measured.The octanol-water partition coefficient (log Pow) ismeasuredto be1.26at 20°C on the basis ofthe shake flask method.The water solubilitywas measured to be 3.19 g/L at 22°C. In physiological circumstances the nitrogen will be positively charged, resulting to a cationic surfactant structure which leads to high adsorptive properties to negatively charged surfaces as cellular membranes. The apolar tails easily dissolve in the membranes, whereas the polar head causes disruption and leakage of the membranes leading to cell damage or lysis of the cell content. As a consequence, the whole molecule will not easily pass membrane structures. Cytotoxicity at the local site of contact through disruption of cell membrane will be considered the most prominent mechanism of action for toxic effects.
Data from acute toxicity studies and irritation studies
Acuteoraltoxicity was evaluated inthe up and down method(OECD 425) study indicating a LD50 of 3129 mg/kg bodyweight. Mortality was observed at5000 mg/kg, where the rats showedhypoactivityabnormal posture and piloerection. At 1750 mg/kg bodyweight, one animal was hypoactive and exhibited facial staining. All animals exhibited ano-genital staining and/or reduced faecal volume. However, these animals recovered by Day 3 and appeared active and healthy for the remainder of the 14-day observation period.
In the acute dermal toxicity study following application, all animals exhibited facial staining and/or ano-genital staining between Days 1 and 2. Also, dermal irritation (erythema, edema, desquamation, hyperkeratosis, discoloration, eschar and/or corrosion) was noted at the dose site of all animals between Days 1 and 14. Gross necropsy of the females revealed red intestines. No gross abnormalities were noted for any of the males when necropsied at the conclusion of the 14-day observation period. Under the study conditions, the acute dermal LD50 of the test substance was greater than 5000 mg/kg bodyweight in male and female rats.
Data from repeated dose toxicity studies
Oral:
Three oral repeated dose toxicity studies were performed with N-[3-(dimethylamino)propyl] C6-9 alkyl amides:
- Repeated Dose 28-Day Oral Toxicity in Rodents (OECD 407)(dietary),
- Combined90 dayRepeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test (OECD 422)(dietary)and
-Preliminary pre-natal development study in rats (oral gavage).
From these studies it can be concluded that:
- Overall there are low to no real systemic effects observed.
- NOAEL systemic effects:175mg/kgbw based onsystemic toxicitywhichwas exhibited at 600 mg/kg/d by clinical findings, lower mean body weights, body weight gains, and food consumption for both sexes and lower absolute and relative-to-brain ovary, uterus, and pituitary weights for the reproductive phase femalesin addition, lower mean live litter size on PND 0, number of pups born and implantation sites, and lower mean pup weights were noted in the 600 mg/kg/daygroup in the presence of excessive maternal toxicity.
The findings observed in these studies suggest that the toxicity of N-[3-(dimethylamino)propyl] C6-9 alkyl amides is rather expressed by local effects than systemic effects.As it was a dietary study and the significantly reduced bodyweight gains at the top dose of 600 mg/kg correlated to the reduced food consumption. This was likely due to unpalatability of the diet due to the test substance. However, there was some indication of reduced food efficiency which could indicate either local or slight systemic toxicity. The reduced nutrition may also explain the reduced number of implants and lower pup weight at birth in the OECD422 study. This lack of any significant systemic effectssupports the lack of bio-accumulating potential of the substance.
Inhalation:
N-[3-(dimethylamino)propyl] C6-9 alkyl amides is aliquidwith a melting point of< -30°C that is marketed or used in aliquidform. Also, the vapour pressure is< 689 Pa. In addition, the use of this substance will not result in aerosols, particles or droplets of an inhalable size, so exposure to humans via the inhalation route will be unlikely to occur.
Dermal:
No data from repeated dose studies via dermal route. N-[3-(dimethylamino)propyl] C6-9 alkyl amides ismildly irritatingto the skin and is not expected to easily pass the skin.
Absorption, distribution, metabolism, excretion
Data on toxicokinetics for N-[3-(dimethylamino)propyl] C6-9 alkyl amides is not available. Due to the apolar alkyl chain, and its adherence to negatively charged surfaces, the substance does not easily pass biological membranes and dermal uptake is therefore very limited.This was supported by the lack of acute dermal toxicity. Athigh concentrations, the apolar tails easily dissolve in the membranes, whereas the polar head causes disruption and leakage of the membranes leading to cell damage or lysis of the cell content. As a consequence, the whole molecule will not easily pass membrane structures. Cytotoxicity at the local site of contact through disruption of cell membrane will be considered the most prominent mechanism of action for toxic effects. However, due to lack of quantitative data, the absorption rate following oral dosing is considered to bethe ECHA default 50%.
Dermal absorption
Based on thedermal LD50 being greater than 5000 mg/kgand N-[3-(dimethylamino)propyl] C6-9 alkyl amides,being only mildly irritating to skin,dermal absorption as a consequence of facilitated penetration through damaged skinis notanticipated.
Due to the lack of quantitative absorption data,the ECHA default of 50% absorption is taken as a conservative approach.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
